SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 6, 2020. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing serves as a Regulation FD disclosure regarding the distribution of a corporate presentation to the investment community.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation (Exhibit 99.1) rather than a financial statement containing quantitative performance data.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The document solely announces the availability of a slide presentation for industry conferences.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to utilize the attached presentation at various industry conferences.
- Forward-Looking Statements: The Company explicitly undertakes no obligation to update, supplement, or amend the materials in the presentation.
- Legal Disclaimer: Information in Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the actual financial data and strategic outlook in Exhibit 99.1 (Corporate Presentation, November 2020), as this 8-K only references the document.
- Confirm that the presentation materials are not legally binding or guaranteed to be updated by the Company.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).